Evidence map›Paper›PMID 34113132›Full record

ArticleInfection and drug resistance2021

Nancy E Lozoya-Pérez, Laura C García-Carnero, José A Martínez-Álvarez, Iván Martínez-Duncker, Héctor M Mora-Montes

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Metabolic Plasticity and Virulence-Associated Factors ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Article
  9. International journal of molecular sciences · 2023
    Article
  10. Review
  11. Ethyl Acetate Fraction ofAntibiotics (Basel, Switzerland) · 2022
    Article
  12. Biological and Clinical Attributes ofInfection and drug resistance · 2022
    Review
  13. Antibacterial and antitumor activities of a lectin-rich preparation fromCurrent research in pharmacology and drug discovery · 2022
    Article
  14. Review
  15. Current Models to Study theFrontiers in fungal biology · 2022
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nancy E Lozoya-PérezDepartamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Guanajuato, 36050, México.
Laura C García-CarneroDepartamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Guanajuato, 36050, México.
José A Martínez-ÁlvarezDepartamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Guanajuato, 36050, México.ORCID 0000-0003-4987-086X
Iván Martínez-DunckerLaboratorio de Glicobiología Humana y Diagnóstico Molecular; Centro de Investigación en Dinámica Celular, Instituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México.
Héctor M Mora-MontesDepartamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Guanajuato, 36050, México.ORCID 0000-0001-6973-0595
Universidad de Guanajuato · MXCentro de Epilepsia y Neurocirugía Funcional · GT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSporotrichosis is an increasing threat for humans, affecting mainly skin and subcutaneous tissues but that can cause disseminated infection in immunocompromised patients.

methods

resultsMortality curves demonstrated that yeast-like cells were the best fungal morphology to kill larvae and showed a similar ranking in virulence than that reported in other animal models, ie, being

conclusionThe study demonstrated that

Indexed as

experimental sporotrichosisfungal infectionhemocyteshost–fungus interplayphenoloxidase

Identifiers

PMID34113132
PMCPMC8184153
OpenAlexW3168254797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.